Novel Development and Therapy in Neovascular Retinal Diseases

Dear Colleagues,

We are pleased to announce the Special Issue entitled “Novel Development, Management and Therapy in Neovascular Retinal Diseases” that aims to collect scientific publications related to neovascular retinal diseases. Neovascular retinal diseases, such as age-related macular degeneration (AMD), diabetic retinopathy (DR), and retinopathy of prematury (ROP), are major causes of vision loss in both adult and pediatric populations. They have caused a heavy burden in the health care system globally. Neovascularization is the proliferation of new blood vessels. These are called intraretinal microvascular abnormalities when the lesion was limited within retina, and retinal neovascularization when these new blood vessels grow to the surface of the retina. Although the reasons to cause neovascularization in retina might vary in different disease entities, neovascularization could result in macular edema due to the breakage of vessel tight junction, vitreous hemorrhage, and retinal detachment if causing vitreous traction on the retina. These pathologies could result in neuronal damage and poor vision of the patients. Recent advances in retinal imaging, telemedicine, surgical instrumentations, molecular sciences, target therapy, such as anti-vascular endothelial growth factor (VEGF) have revolutionized we way we take care of these patients with neurovascular retinal disease. The exploration of these new developments could result in better understanding of disease pathogenesis, and generation of novel management and new therapy for the patients.

In this Special Issue, we target on all aspects of  neovascular retinal diseases. Research articles, review articles, case series, as well as communications are welcomed.

Dr. Wei-Chi Wu
Dr. Jay Chhablani
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.